Diabetes Insipidus (DI) is defined as the passage of large volumes (>3 litres in 24 hours) of dilute urine (< 300 mOsm/kg). It can arise as a result of:
- Reduced pituitary/hypophyseal secretion of antidiuretic hormone ADH (Cranial Diabetes Insipidus). This occurs infrequently following traumatic brain injury.
- Cranial Diabetes Insipidus can also occur in association with tumours in the suprasellar/intrasellar region (adjacent to the pituitary) or following intracranial vascular injury or inflammatory cerebral lesions.
- Increased renal resistance to the action of ADH in the kidney (Nephrogenic Diabetes Insipidus). This can be caused by renal disorders or in response to specific medications.
Note: They can both lead to hypernatraemia.
Differential Diagnosis: Hypernatraemia can also be caused by:
- Inadequate water intake.
- Excessive water loss (e.g. diabetes mellitus, diuretic medication, renal disease).
- Excessive extra-renal water loss (e.g. extreme sweating, diarrhoea, vomiting, intestinal fistulas, significant burns).
- Excess solute intake/infusion.
- Excessive sodium retention (hyperaldosteronism/Conn’s Syndrome).
Clinical Features of Hypernatraemia are non-specific and include:
- Dehydration.
- Confusion.
- Lethargy.
- Muscle jerks (myotonia).
NOTE: If untreated hypernatraemia can lead to seizures or coma.
In addition Diabetes Insipidus is associated with the following specific clinical features:
- Polyuria i.e. urine output of 3-20 litres per day.
- Polydipsia (thirst).
- Nocturia.
Diagnostic Investigations
The diagnosis of Diabetes Insipidus is based on measuring:
- Increased 24-hour urine volume.
- Reduced urine osmolarity.
- Increased plasma osmolarity and plasma sodium.
The exclusion of Diabetes Mellitus as a cause of polyuria is also important in differential diagnosis.
To discriminate between cranial and nephrogenic Diabetes Insipidus measure:
- Serum ADH.
- Water deprivation test.
Treatment options for cranial Diabetes Insipidus include:
- Increasing oral intake.
- Intravenous hypoosmolar fluid.
- Desmopressin(synthetic ADH) for cranial diabetes insipidus.
NOTE: You should seek senior medical advice or consult your employing health authority’s specific management protocols for investigation and management of this condition.